Phase I Study of High-Dose L-methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH wild-type High-Grade Glioma.
Salas LA, Stewart TG, Mobley BC, Peng C, Liu J, Loganathan SN, Wang J, Ma Y, Berger MS, Absher D, Hu Y, Moots PL, Christensen BC, Clark SW.
Salas LA, et al. Among authors: peng c.
Cancer Res Commun. 2022 Jan;2(1):1-9. doi: 10.1158/2767-9764.CRC-21-0088.
Cancer Res Commun. 2022.
PMID: 35392283
Free PMC article.
Clinical Trial.